Table 4 Topics rated as being "very important" or "quite important".
From: Identifying structures, processes, resources and needs of research ethics committees in Egypt
| Topics | Percentage of RECs reporting |
|---|---|
| The use of placebo controlled trials | 100% (10/10) |
| Determination of methods to reduce risk | 92% (11/12) |
| The interpretation of pre-clinical studies | 91% (10/11) |
| Determination of risks in research | 91% (10/11) |
| Assessment of benefits to participants and society | 90% (9/10) |
| Scientific design issues in clinical trials | 90% (9/10) |
| Monitoring and oversight of approved studies | 90% (9/10) |
| Assessment of cultural sensitivity for informed consent | 82% (9/11) |
| Assessment of understanding of informed consent | 80% (8/10) |
| Access to benefits after the trial is over | 78% (7/9) |
| Determination of appropriate subject selection in vulnerable populations | 75% (9/12) |
| Community participation | 67% (6/9) |
| Social and behavioral studies | 75% (9/12) |
| Privacy and confidentiality | 70% (7/10) |